Target intelligence / Profile preview

Agglutinin-like protein 3 (Als3p)

Target
Als3p
Molecular classification
Cell wall protein, Adhesin, Invasin, GPI-linked protein, Glycoprotein
01

Overview

Agglutinin-like protein 3 (Als3p) is a hyphal-specific cell wall glycoprotein in Candida albicans that belongs to the agglutinin-like sequence (ALS) family. It serves as a multifunctional virulence factor, acting as both an adhesin that mediates attachment to host cells and extracellular matrix proteins, and an invasin that triggers host cell endocytosis by mimicking mammalian cadherins such as E-cadherin and N-cadherin. Als3p is also critical for the formation of robust biofilms on medical devices and facilitates fungal iron acquisition by binding to host ferritin. Because of its essential role in pathogenesis and high expression during infection, the N-terminal domain of Als3p has been utilized as the primary antigen in the NDV-3 and NDV-3A vaccines. These immunotherapies aim to elicit protective antibody and T-cell responses to prevent various forms of candidiasis, including recurrent vulvovaginal and disseminated infections. Clinical trials have demonstrated the safety and immunogenicity of targeting this domain, showing significant protection in specific patient populations. Beyond vaccines, Als3p is a target for several monoclonal antibodies that block its adhesive and invasive functions. The protein's unique expression on hyphae makes it a specific marker for the invasive phase of the fungus.

Other names
Agglutinin-like sequence 3 proteinAls3rAls3p-NCandida albicans Als3pAgglutinin-like protein 3 N-terminal domain
02

Mechanism of action

Vaccination with the recombinant N-terminal domain of Als3p (rAls3p-N) induces protective Th1 and Th17 cellular immune responses and high titers of neutralizing antibodies, particularly the IgG2 subclass. These antibodies block fungal adhesion to host tissues, inhibit invasion by preventing binding to host cadherins, and enhance opsonophagocytic killing by neutrophils and macrophages.

03

Biological functions

Cell adhesionHost cell invasionBiofilm formationIron acquisitionCell aggregation
04

Disease associations

CandidiasisOropharyngeal candidiasisVulvovaginal candidiasisDisseminated candidiasisBiofilm-associated infection
05

Safety considerations

Theoretical cross-reactivity with host cadherins due to molecular mimicryHyphal-specific expression limits targeting of the yeast phaseFunctional redundancy within the ALS protein family
06

Interacting drugs

NDV-3

4 more in the full profile.

07

Biomarkers

Anti-Als3p IgG2 antibody titers

Beyond the preview

Go deeper on Agglutinin-like protein 3 (Als3p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agglutinin-like protein 3 (Als3p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call